Literature DB >> 29519557

Acute pancreatitis conditioned mesenteric lymph causes cardiac dysfunction in rats independent of hypotension.

Satyanarayan T Shanbhag1, Bernard Choong2, Maxim Petrov3, Brett Delahunt4, John A Windsor5, Anthony R J Phillips1.   

Abstract

BACKGROUND: Critical illness including severe acute pancreatitis is associated with the multiple organ dysfunction syndrome. The "gut-lymph" hypothesis states that multiple organ dysfunction syndrome is due to release of toxic factors from the intestine into the mesenteric lymph. The aims of this study were to determine the effect of normotensive acute pancreatitis conditioned mesenteric lymph on cardiac function and whether external drainage of mesenteric lymph would protect the heart.
METHODS: Groups of normal rats and those with normotensive taurocholate induced acute pancreatitis, had either no lymphatic intervention or thoracic duct ligation and external drainage of mesenteric lymph. After 6 hours, the hearts were removed for ex vivo functional measurements, including cardiac output, ventricular contractility (+dP/dt), and relaxation (-dP/dt). In a second experiment, mesenteric lymph from normal rats and those with established acute pancreatitis was infused into ex vivo perfused normal working rat hearts to assess impact on cardiac function. Heart and lung tissues were collected for assessment of edema.
RESULTS: Significant cardiac dysfunction, denoted by decreased cardiac output (21%), contractility (37%), relaxability (23%), and increased cardiac tissue edema (2-fold), developed in rats with established acute pancreatitis and no lymphatic intervention compared with the control group (all P < .05). Strikingly this cardiac dysfunction and edema was normalized in acute pancreatitis rats that had undergone prior thoracic duct ligation and external drainage of mesenteric lymph. In the second experiment, infusion of acute pancreatitis conditioned mesenteric lymph resulted in an immediate and significant similar magnitude decrease in of cardiac output (17%), contractility (22%), and relaxation (27%) compared with the infusion of normal lymph (all P <.05).
CONCLUSION: Mesenteric lymph from normotensive acute pancreatitis animals caused significant cardiac dysfunction which could be prevented by thoracic duct ligation and external drainage of mesenteric lymph.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29519557     DOI: 10.1016/j.surg.2017.12.013

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Influence of Intestinal Lymphatic Ligation on Pulmonary Injury in Rats with Severe Acute Pancreatitis.

Authors:  Yuan-Qi Liu; Lu-Lu Wang; Li Chen; Yu-Xia Xiong
Journal:  Curr Med Sci       Date:  2022-08-13

2.  Anatomy of the lymphovenous valve of the thoracic duct in humans.

Authors:  Lomani Archibald O'Hagan; John Albert Windsor; Anthony Ronald John Phillips; Maxim Itkin; Peter Spencer Russell; Seyed Ali Mirjalili
Journal:  J Anat       Date:  2020-02-27       Impact factor: 2.921

3.  Improving Small Intestinal Motility in Experimental Acute Necrotising Pancreatitis by Modulating the CPI-17/MLCP Pathway Using Chaiqin Chengqi Decoction.

Authors:  Ziqi Lin; Chenlong Zhang; Xiaoxin Zhang; Na Shi; Yongjian Wen; Chengxia Han; Dan Du; Tingting Liu; Tao Jin; Lihui Deng; Kun Jiang; Xiaonan Yang; Jia Guo; Anthony Philips; Robert Sutton; John A Windsor; Wei Huang; Ping Xue; Qing Xia
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-10       Impact factor: 2.629

Review 4.  Management of Severe Acute Pancreatitis.

Authors:  Peter J Lee; Georgios I Papachristou
Journal:  Curr Treat Options Gastroenterol       Date:  2020-11-19

Review 5.  Comprehensive Mechanism, Novel Markers and Multidisciplinary Treatment of Severe Acute Pancreatitis-Associated Cardiac Injury - A Narrative Review.

Authors:  YaLan Luo; ZhaoXia Li; Peng Ge; HaoYa Guo; Lei Li; GuiXin Zhang; CaiMing Xu; HaiLong Chen
Journal:  J Inflamm Res       Date:  2021-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.